Lund, Sweden

Marguerite Mensonides-Harsema


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marguerite Mensonides-Harsema: Innovator in Pharmaceutical Compounds

Introduction

Marguerite Mensonides-Harsema is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

Her latest patents include groundbreaking inventions related to pharmaceutical compounds. The first patent provides compounds of formula (I), wherein m, R, n, R, q, X, Y, Z, t, R, R, R, R, R, and R are defined in the specification. This invention outlines processes for their preparation, pharmaceutical compositions containing them, and their use in therapy. The second patent focuses on tricyclic spiropiperidines or spiropyrrolidines, also providing compounds of formula (I) with similar definitions and applications in therapy.

Career Highlights

Marguerite works at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves extensive research and development in the pharmaceutical sector, contributing to innovative solutions for various health challenges. Her expertise in compound formulation has been instrumental in advancing therapeutic options.

Collaborations

Marguerite has collaborated with talented coworkers, including Nafizal Hossain and Svetlana Ivanova. These collaborations have fostered a dynamic research environment, enhancing the potential for innovative discoveries in their field.

Conclusion

Marguerite Mensonides-Harsema's contributions to pharmaceutical innovations exemplify her dedication to advancing healthcare solutions. Her patents reflect her commitment to improving therapeutic applications through innovative compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…